Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered cells expressing anti-viral T cell receptors and methods of use thereof

Engineered cells expressing anti-viral T cell receptors and methods of use thereof

US Patent 11421220 · Granted Aug 23, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered cells expressing anti-viral T cell receptors and methods of use there2025
Engineered cells expressing anti-viral T cell receptors and methods of use there2025
Engineered cells expressing anti-viral T cell receptors and methods of use there2025
Engineered cells expressing anti-viral T cell receptors and methods of use there2025
Engineered cells expressing anti-viral T cell receptors and methods of use there2025
Engineered cells expressing anti-viral T cell receptors and methods of use there2025
Anti-CTLA-4 binding proteins and methods of use thereof2025
Anti-CTLA-4 binding proteins and methods of use thereof2025
Anti-CTLA-4 binding proteins and methods of use thereof2025
Anti-CTLA-4 binding proteins and methods of use thereof2025
Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof2025
Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof2025